米纳瑞斯制药 MLYS
$15.33 +$0.09 (+0.59%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.33 0.00%
开盘$15.23
昨收$15.24
当日区间$14.91 – $15.65
成交量1.34M
市值$1.36B
市盈率（TTM）–
股息率–
MLYS 相关新闻
匹配 Mineralys Therapeutics 或代码 MLYS 的头条新闻，按最新排序。
- Mineralys Therapeutics(MLYS.US) Director Sells US$3.01 Million in Common Stock
- Form 144 | Mineralys Therapeutics(MLYS.US) Director Proposes to Sell 3.01 Million in Common Stocks
- Analysts Offer Insights on Healthcare Companies: Monte Rosa Therapeutics (GLUE), Mineralys Therapeutics, Inc. (MLYS) and Adagene (ADAG)
- A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $40 to $56
- Bank of America Securities Sticks to Its Buy Rating for Mineralys Therapeutics, Inc. (MLYS)
- LifeSci Capital Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $54
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Intuitive Surgical (ISRG), Legend Biotech (LEGN) and Mineralys Therapeutics, Inc. (MLYS)
- H.C. Wainwright Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $56
- Mineralys Therapeutics, Inc. (MLYS) Gets a Buy From Wells Fargo
- Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), Mineralys Therapeutics, Inc. (MLYS) and ArriVent BioPharma, Inc. (AVBP)
- Goldman Sachs Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating, Maintains Target Price $42
- A Quick Look at Today's Ratings for Mineralys Therapeutics(MLYS.US), With a Forecast Between $42 to $56
- Analysts Have Conflicting Sentiments on These Healthcare Companies: Collegium Pharmaceutical (COLL), Myriad Genetics (MYGN) and Mineralys Therapeutics, Inc. (MLYS)
- Analysts Are Bullish on These Healthcare Stocks: Mineralys Therapeutics, Inc. (MLYS), Context Therapeutics (CNTX) 正面
- TD Cowen Maintains Mineralys Therapeutics(MLYS.US) With Buy Rating
暂无评论——快来第一个聊聊 MLYS。
登录后参与讨论。